In Vivo Targeting of Xenografted Human Cancer Cells with Functionalized Fluorescent Silica Nanoparticles in Zebrafish

作者： Xiaodan Qin*1, Fabrice F. J. Laroche*1, Saquib Ahmed M. A. Peerzade2, Andrew Lam1, Igor Sokolov2,3,4, Hui Feng1 1Departments of Pharmacology and Medicine, Section of Hematology and Medical Oncology, The Cancer Research Center,Boston University School of Medicine, 2Department of Biomedical Engineering,Tufts University, 3Department of Mechanical Engineering,Tufts University, 4Department of Physics,Tufts University

简介：

Overview

This article describes a method for using zebrafish embryos to study the targeting ability of functionalized nanoparticles on human cancer cells in vivo. The procedure enables researchers to evaluate and select optimal nanoparticles for future testing in larger animal models and clinical trials.

Key Study Components

Area of Science

• Nanoparticle targeting
• Cancer research
• Zebrafish models

Background

• Functionalized nanoparticles have potential in cancer therapy.
• Zebrafish embryos are a useful model for in vivo studies.
• Evaluating targeting efficiency is crucial for clinical applications.
• This method simplifies the selection process for effective nanoparticles.

Purpose of Study

• To assess the ability of nanoparticles to target human cancer cells.
• To determine the efficiency of nanoparticle targeting in vivo.
• To facilitate the selection of nanoparticles for further testing.

Methods Used

• Use of zebrafish embryos for in vivo studies.
• Evaluation of functionalized nanoparticles.
• Assessment of targeting efficiency on human cancer cells.
• Procedure demonstration by lab personnel.

Main Results

• Successful demonstration of nanoparticle targeting in zebrafish.
• Identification of optimal nanoparticles for further research.
• Establishment of a method for future clinical trials.
• Insights into the efficiency of targeting mechanisms.

Conclusions

• The method provides a reliable way to study nanoparticle targeting.
• It supports the development of effective cancer therapies.
• Future studies can build on these findings for clinical applications.

Frequently Asked Questions